two exciting new drugs for rheumatoid arthritis

You'll soon see two exciting new drugs for rheumatoid arthritis...Arava (Ah-RAY-va, leflunomide) and Enbrel (EN-brel, etanercept).

These will be the first disease-modifying drugs for rheumatoid arthritis (RA) to be approved in over 10 years.

Disease-modifying drugs actually slow joint destruction...aspirin and NSAIDs just relieve symptoms.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote